A strength is not competitive because you hold it. It is competitive only if a buyer would pay for the difference and a capable rival would struggle to close it.
Open almost any strategy document and the differentiators will include reliability, responsiveness, technical quality and a team with deep experience. Each claim is usually true. None is a differentiator: the rival you are trying to displace claims the same four, their customers believe them, and the buyer between you cannot tell you apart.
This would be presentational if strength claims stayed inside the document. They do not. They set the premium the commercial team is told to defend, the capabilities the capital plan funds, the argument to the board about why one unit is retained and another divested. A misclassified strength produces a mispriced strategy, and the error is durable, because nothing in the reporting cycle revisits it.
The exercise that follows shortens the list. What remains is harder to present and considerably more useful, because for the first time it can be funded deliberately.
The Strategic Context
Michael Porter drew the distinction that governs this question when he separated operational effectiveness from strategy: performing similar activities better than rivals is operational effectiveness, while strategy means performing different activities, or similar activities differently [SOURCE DETAILS REQUIRED]. Operational effectiveness is necessary and its benefit transient, because good practice diffuses — through people, advisers, and customers who describe what your rival does.
The two categories require opposite investment logics. Operational effectiveness is funded to a threshold set outside the organisation and held there. Competitive advantage is funded past the point where the return is obvious, because obviousness invites imitation.
Most enterprises run one logic for both. They invest continuously in what everyone can see and measure, and intermittently in what is difficult, unmeasured and genuinely theirs. The result reads as operational discipline and behaves as competitive drift.
Why the List Never Shrinks
Four habits keep the strength list long.
The first is that the comparative step is skipped. "Are we good at this?" is answered from internal history. "Are we better than the alternative the customer is genuinely considering?" requires outside evidence, which most businesses do not collect.
The second is that the setting selects for affirmation. Strength claims are generated in a room of the executives accountable for each function, so challenging a claim challenges a colleague, and the list becomes a negotiated document rather than an assessment.
The third is confusing what customers praise with what they chose on. Praise is post-purchase and polite. The decision was often made on something never mentioned — availability on the required date, an existing relationship, a specification written around an incumbent.
The fourth is treating a personal strength as an organisational one. A capability resident in three people is an asset with a resignation risk attached: distinctive, perhaps, but not yet a competitive position, because a competitive position survives a departure.
Reframing the Issue
Two tests, both requiring evidence from outside the building, do most of the classification work.
Would a customer choose us, or pay more, specifically because of this? And could a capable competitor match it within one budget cycle if they decided to?
Pass both and the strength is competitive. Fail the second and it is common — real, necessary, unable to carry a price. Fail the first and it is irrelevant however hard it was to build — the most expensive category, because organisations invest for years in capabilities customers do not value and read the absence of reward as a communication problem.
Underneath both sits an asymmetry. Entry conditions are necessary and not sufficient; their payoff is one-sided — failing to hold them disqualifies you, excelling at them differentiates nothing.
Common Strengths Are Insurance, Not Advantage
Reliability, responsiveness, conformance, compliance and safety are downside-only assets. That is not a criticism: insurance is valuable because of what it prevents, and losing one of these costs access to the market rather than a point of margin.
The allocation rule follows: fund to threshold, then stop. The threshold is set by customer expectation and the best available alternative, not by internal ambition, and it rises as rivals improve. Over-investment beyond it is a misallocation presenting itself as excellence, invisible in reporting because the metric it improves keeps improving.
Philip Crosby's definition is useful discipline: quality is conformance to requirements, and the cost that matters is the cost of non-conformance [SOURCE DETAILS REQUIRED]. Expenditure beyond conformance is not quality investment; it is discretionary spend requiring its own business case. Shigeo Shingo's argument for preventing defects at source rather than detecting them downstream is the operational counterpart [SOURCE DETAILS REQUIRED], pointing at the right ambition for any table stake — hold it at lower cost than rivals, since holding it cannot differentiate you.
The market test is unforgiving: a real advantage should be visible in realised price. Where it is not, either the strength is common or the organisation is failing to convert it — different responses entirely [Related article: Price Is a Share of Value Created, Not a Markup on Your Cost].
Common Weaknesses, Catastrophic Weaknesses, and Profit-Eaters
The same discipline applies on the other side of the ledger, where it is used even less.
Common weaknesses are shared across the sector and absorbed by everyone in it: limited recognition in a segment you have just entered, thin management depth in a fast-growing business, cash cycles that lag delivery. They warrant management, rarely alarm.
Catastrophic weaknesses end the business or its licence to operate: a structural flaw in service delivery the operating model cannot correct; a core segment in genuine decline rather than cyclical weakness; a missing accreditation that is a precondition to bid. And the one almost never on a risk register — an inability to learn, which makes every other weakness permanent.
Profit-eaters are the third class and the one that goes unmanaged: not fatal, not visible in strategy discussion, draining margin continuously — rework, unpriced scope, concessions below the delegation threshold, capacity consumed by work nobody chose to take, remediation absorbed into overhead.
Enterprise attention is close to inverted. Boards address catastrophic weakness, correctly, because it is governance; and common weakness comfortably, because improvement programmes are pleasant to sponsor. They rarely address profit-eaters, because each instance sits below the reporting threshold and only the aggregate is material — and nothing aggregates them.
The triage rule is blunt. Catastrophic first, always. Profit-eaters second, because they fund everything else and the money is already being spent. Common weaknesses last, and only where one blocks a pathway the strategy depends on.
The Four Adversarial Questions
One exercise surfaces more in ninety minutes than most strategy offsites produce in two days, provided it is run with discipline. Four questions, answered by the leadership team:
- If you were your own competitor, how would you attack this business?
- If you were a customer of this business, what would frustrate you?
- If you were buying this business, what would you change in the first month?
- What would a critical customer say about us that we wish were not true?
Each reaches different material. The first surfaces the vulnerability structure — which profitable segment a rival could take cheaply, and with what. The second surfaces friction the organisation has normalised. The third is the most productive, because it retrieves changes leadership already knows are needed and has deferred; an acquirer has no sunk history and no relationships to protect. The fourth surfaces the reputational fact everyone knows and has agreed not to say aloud.
How it is run determines whether it produces anything. Answers are written individually before discussion, because the first spoken answer sets the range for every later one. In the first round the executive accountable for a function may not respond to criticism of it. The attacker role in question one is assigned, not volunteered, and must produce a plan with a price. Question three is answered with a cost and a date; question four in the customer's own words wherever they exist — lost-bid debriefs, complaints, service records — because paraphrase is where the discomfort gets removed.
The exercise has one dependable failure mode: run by incumbent leadership on itself, it produces charitable answers. The correction is an outside challenger, or a rule that every response must name something that would cost money to fix. Where that challenger comes from is its own selection problem [Related article: How Do You Tell a Competent Adviser From a Confident One?].
The Competitors You Never Counted
Most competitive analysis counts firms sharing an industry classification. The buyer does not think in those terms; the question matching how they decide is simpler: if we did not exist, what would this customer do on Monday?
The answers are mostly not firms. They would do nothing and live with the problem — in most markets the single largest competitor. They would do it internally. They would buy a partial substitute from an adjacent category and accept the shortfall. They would meet the underlying need another way: Clayton Christensen's framing of the job a customer hires a product to do is the useful lens, because substitutes compete at the level of the job, not the product category [SOURCE DETAILS REQUIRED]. Or they would delay until a budget cycle, a regulatory date or a failure forced the decision.
Porter's treatment of substitutes as a distinct competitive force belongs here, and is routinely reduced to a slide naming two adjacent products [SOURCE DETAILS REQUIRED].
The consequences are specific and expensive. Win-loss data is misattributed, losses recorded against named rivals when the outcome was deferral — pointing investment at competitive response when the barrier was a business case, a switching cost or a budget date. Pricing is calibrated against a set that excludes the cheapest alternative, inaction. And differentiation is measured only against firms sharing your assumptions, so a whole class of vulnerability never appears.
The instrument is unglamorous: a written map of indirect alternatives with a named owner, refreshed annually, populated from debriefs carrying one mandatory question — what else did you consider, including doing nothing? A discount request is a related signal, reporting options or objections rather than a fault in the number [Related article: What a Discount Request Is Actually Reporting].
Decision Framework
Take each claimed strength in the strategy document and put it through five tests.
| Test | Question to ask of the claimed strength | What a negative answer means |
|---|---|---|
| Willingness to pay | Do customers choose us, or pay more, because of it? | Not competitive, whatever it cost to build |
| Replicability | Could a capable rival match it within one budget cycle? | Common; fund to parity and cap the spend |
| Visibility | Can a buyer perceive it before they purchase? | Real but uncommunicated — commercial, not strategic |
| Durability | Does it survive the departure of our three best people? | A personal asset, not an organisational position |
| Evidence | Can we cite external evidence rather than internal opinion? | Aspirational; test it before funding it |
Three thresholds convert classification into decisions. Anything failing replicability is funded to parity and capped, the cap reviewed annually. Anything failing willingness to pay stops attracting investment or starts attracting a price. Anything passing all five is funded past the point of obvious return, the only category where investment compounds rather than dissipates.
From Strategy to Execution
Immediately, reclassify every differentiator against the five tests and delete what fails. It takes a morning, produces a shorter deck and a clearer capital plan, and is the rare strategic exercise with no implementation cost.
Over the medium term, build the evidence system that makes classification honest: structured win-loss debriefs including the question about alternatives; a ledger aggregating below-threshold margin leakage so profit-eaters become visible at the scale that matters; and the four adversarial questions run annually with the discipline described.
The long-term position rests on two facts. Advantage decays, because rivals converge and today's competitive strength becomes tomorrow's entry condition, making classification a recurring obligation rather than a conclusion. And it must be systematised to count: a capability held in three people's judgement has to become a method, a standard and a training obligation before it can be defended, priced or sold.
Signals to Monitor
Watch discount requests concentrating on one offering, reporting options or unresolved objections rather than a pricing error. Watch win rates holding steady while average deal size falls. Watch whether "no decision" can even be recorded in your loss data; if not, you are structurally blind to your largest competitor. Watch customers who renew but never expand. Watch a capability improving on internal metrics while realised price stays flat, the clearest evidence that a claimed differentiator is common. And watch how quickly rivals match anything you announce, because the interval measures replicability.
Questions for the Leadership Team
- Which strengths in our strategy document would survive the willingness-to-pay test with external evidence attached, and who has tested them?
- What are we funding to the level of advantage that should be funded only to parity — and what would we do with the difference?
- If a well-capitalised competitor took our most profitable segment, what would they attack first, and how long before we noticed?
- What is the aggregate annual value of our profit-eaters, and does anyone own that number?
- In our last twenty losses, how many were to a named competitor and how many to deferral, in-house delivery or a substitute?
Closing Perspective
A strength list is a capital allocation instrument wearing the costume of a description. Every item implies a claim about where money should go, what price can be held and which vulnerabilities can be left unattended — and most have never been tested outside the organisation that produced them.
The discipline this asks for is subtraction, harder to sponsor than addition. A leadership team that can name one capability a capable rival would struggle to copy, show the evidence, and state what it is worth in realised price is in a stronger position than one carrying nine claims and no test. The nine-claim version is not the more capable business. It is the less examined one, already spending money as though every claim were true.
About EraNorth Insights
EraNorth Insights publishes practical analysis on strategy, projects, operations, transformation and decision intelligence for professional and organisational use. About EraNorth.